Prof. Stanka Romac (1954-2015) realized his vision of a laboratory oriented towards the application of molecular biology in response to the needs of society by establishing the Center for the Application and Development of PCR in 1997, which has been called the Center for Human Molecular Genetics since 2008. The Center introduced the first genetic tests for neurological diseases and plant viruses and forensic DNA analysis, thus leaving a deep mark on the development of molecular genetics in Serbia. Today, the Center's activities include genetic testing for more than 60 rare diseases, paternity testing, and DNA sequencing services, and its users include medical institutions from the country and the region, courts, institutes, and faculties.

Of particular importance is the introduction of neonatal screening for spinal muscular atrophy (SMA) in 2022. Thanks to these activities, hundreds of healthy children have been born into families with rare diseases, more than 1000 court cases for disputed paternity have been resolved, and asymptomatic SMA babies have received therapy. In the era of genetic therapies and personalized medicine, the Center's research is aimed at understanding the molecular basis of individual patient variability and identifying non-invasive prognostic biomarkers for rare neuromuscular diseases, prostate cancer, and suicidal behavior. Scientific activity is supported by projects of the relevant Ministry, the Science Fund of the Republic of Serbia, pharmaceutical companies, and domestic and international cooperation.

Prof. Dušanka Savić-Pavićević is the head of the Center and the administrator of the "Stanka Romac" Foundation, which annually awards a doctorate in the field of Biomedicine or Human Molecular Genetics.